Fell Donald G.'s Form 4 filing
Aspire Biopharma Holdings, Inc. (ASBP) · filed Jun 6, 2025
- Accession no.
- 0001641172-25-014102
- Filed
- Jun 6, 2025, 5:00 PM ET
- Trade date
- Jun 4-5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $7.80K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001641172-25-014569 (Jun 10, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fell Donald G.CIK 0001616905 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | Common Stock, par value $0.0001 | PPurchaseDisposed | −9,500 | $0.39 | −$3,705 | 9,500 | Direct | |
| Jun 5, 2025 | Common Stock, par value $0.0001 | PPurchaseDisposed | −10,500 | $0.39 | −$4,095 | 20,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.